Journal Mobile Options
Table of Contents
Vol. 126, No. 4, 2011
Issue release date: November 2011
Add to my selection Citation Download
Acta Haematol 2011;126:234–237
(DOI:10.1159/000330529)
Brief Communication

Unusual Course of Myelodysplastic Syndrome with Presumed Familial Origin

Bacher U.a · Ocheni S.a, d · Schafhausen P.b · Oyekunle A.a, e · Dierlamm J.b · Zander A.R.a · Bokemeyer C.b · Haferlach T.c · Kröger N.a
Departments of aStem Cell Transplantation and bOncology and Hematology, University Cancer Center Hamburg, Hamburg, and cMLL Munich Leukemia Laboratory, Munich, Germany; dDepartment of Hematology and Immunology, University of Nigeria, Enugu, and eDepartment of Hematology and Immunology, Obafemi Awolowo University, Ile-Ife, Nigeria Acta Haematol 2011;126:234–237 (DOI:10.1159/000330529)

First-Page Preview
Abstract of Brief Communication

 goto top of outline Author Contacts

PD Dr. med. Ulrike Bacher, MD
Department of Stem Cell Transplantation, University Cancer Center Hamburg
Martinistrasse 52
DE–20246 Hamburg (Germany)
Tel. +49 4 7410 54154, E-Mail u.bacher@uke.de


 goto top of outline Article Information

Received: May 10, 2011
Accepted after revision: June 26, 2011
Published online: September 22, 2011
Number of Print Pages : 4


 goto top of outline Publication Details

Acta Haematologica

Vol. 126, No. 4, Year 2011 (Cover Date: November 2011)

Journal Editor: Ben-Bassat I. (Qiryat-Ono)
ISSN: 0001-5792 (Print), eISSN: 1421-9662 (Online)

For additional information: http://www.karger.com/AHA


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.